Advances in Targeted Therapy for NSCLC: What Is the Importance of Biopsies in Identifying Acquired Resistance Mutations at Progression? How to Determine Who Will Benefit From Oral TKIs?
By
Yale Cancer Center
FEATURING
Anne Chiang
By
Yale Cancer Center
FEATURING
Anne Chiang
Login to view comments.
Click here to Login